ZWEIFACH SANFORD S 4
4 · Carisma Therapeutics Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
ZWEIFACH SANFORD S
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2023-06-06+38,700→ 38,700 totalExercise: $7.25Exp: 2033-06-06→ Common Stock (38,700 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over three years in equal monthly installments following June 6, 2023, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
Signature
/s/ Richard Morris, as Attorney-in-Fact for Sanford Zweifach|2023-06-08